trial

Minnesota Community-Based Cognitive Training in Early Psychosis

NCTId NCT03079024
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 45 (actual)
Sponsored by University of Minnesota
Primary completion 2022-03-26
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
45 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2017-05-19
Primary completion
2022-03-26
Eligibility
ALL · 16 Years · 35 Years

Interventions & indications

Drugs
Targeted cognitive trainingGeneral Cognitive ExercisesCoordinated Specialty Care for First Episode Psychosis

Sponsors

University of MinnesotaLead Sponsor
University of California Riverside at C.I. Trials, Inc.-Inland EmpireCollaborator

Investigators

1
Sophia Vinogradov, MDPrincipal Investigator

Sites

1 total
Minneapolis, United States

Facts & assertions

4 sourced
Enrollment
45
Phase
NA
Primary Completion Date
2022-03-26
Status
COMPLETED
relationships
The graph out of here
drug
Targeted cognitive training
drug
General Cognitive Exercises
drug
Coordinated Specialty Care for First Episode Psychosis
drug
lead_sponsor
University of Minnesota
company
collaborator
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
indication
Unspecified Psychosis
indication
Schizophreniform Disorders
indication
Schizoaffective Disorder
indication
investigator
Sophia Vinogradov, MD
person